In silico determination of novel SARS-CoV-2 envelope protein ion channel inhibitors
The SARS-CoV-2 envelope protein (2-EPRO), a viroporin crucial for viral pathogenesis, is a promising target for antiviral drug development as it is highly conserved and functionally important. Although it is a promising therapeutic target for the treatment of COVID-19, it has often been overlooked i...
Saved in:
| Main Authors: | Nina Kobe, Lennart Dreisewerd, Matic Pavlin, Polona Kogovšek, Črtomir Podlipnik, Uroš Grošelj, Miha Lukšič |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Computational and Structural Biotechnology Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037025002557 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening and discovery of an antiviral candidate inhibiting the SARS-CoV-2 envelope (2-E) channel
by: Han Zhang, et al.
Published: (2025-01-01) -
Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01) -
A Modern View on the Treatment for Acute Calcium Channel Blocker Poisoning
by: A. Yu. Simonova, et al.
Published: (2024-09-01) -
Efficacy of insulin therapy in severe poisoning with calcium channel blockers
by: A. Yu. Simonova, et al.
Published: (2023-12-01) -
The vasorelaxant effect of Adiantum capillus-veneries extract in the vascular activity of goat’s isolated renal artery
by: Aveen Muhsen Asaad, et al.
Published: (2023-09-01)